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Abstract 15 
Classical swine fever (CSF) is a highly contagious febrile viral disease caused by CSF virus 16 
(CSFV) and it is considered one of the most important infectious diseases that affect domestic pigs and 17 
wild boar. Previous molecular epidemiology studies have revealed that the diversity of CSFV comprises 18 
three main genotypes and different subgenotypes defined by using a reliable cut-off to accurately classify 19 
CSFV at genotype and subgenotype levels. However, a growing number of CSFV both complete genome 20 
and full E2 gene sequences have been submitted to GenBank (more than 500 sequences are currently 21 
available, revised on December 1st, 2017).  Therefore, the aim of the current study was to revisit the 22 
taxonomy of CSFV at genotype and subgenotype levels, to unify nomenclature and to provide an update 23 
to the classification of CSFV. We propose here a new genotyping scheme with five well defined CSFV-24 
genotypes (CSFV-Genotype1-5) and 14 subgenotypes (seven for each of the CSFV-Genotype1 and 25 
CSFV-Genotype2). The findings showed in the current study are relevant for molecular epidemiology 26 
approaches and will help to better understand the genetic diversity and spreading of CSFV at a global 27 
scale. The update in the classification of CSFV will allow the scientific community to establish more 28 
accurately the links among different outbreaks of the disease.  29 
30 
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Introduction 31 
Classical swine fever (CSF) is a highly contagious febrile viral disease, considered one of the 32 
most important infectious diseases that affect domestic pigs and wild boar (Sus scrofa) (Blome et al., 33 
2017). Because of its huge economic impact, the disease is notifiable to the World Organisation of 34 
Animal Health (OIE) (Moennig et al., 2013). Even though CSF has been successfully eradicated from 35 
some countries including Canada, United States, Australia and New Zealand; it remains to have a severe 36 
impact on Asia, Eastern Europe and most of South and Central America as well as the Caribbean (Postel 37 
et al., 2017).  38 
CSF is caused by CSF virus (CSFV), a small-enveloped RNA virus of the genus Pestivirus 39 
included into the Flaviviridae family. The CSFV genome consists of a single plus-stranded RNA, which 40 
contains one large open reading frame (ORF) flanked by two untranslated regions (UTRs). The ORF 41 
encodes a polyprotein of approximately 3900 amino acids which is subsequently processed by cellular 42 
and viral proteases into mature proteins: four structural proteins (C, Erns, E1 and E2) and 8 non-structural 43 
proteins (Npro, P7, NS2, NS3, NS4A, NS4B, NS5A, NS5B)(Meyers and Thiel, 1996). 44 
 Previous molecular epidemiology studies have revealed that the diversity of CSFV comprises 45 
three main genotypes and different subgenotypes (Postel et al., 2013). To establish an international 46 
consensus for CSFV’s classification system, a recent study assessed the reliability of the phylogenetic 47 
markers most commonly used in molecular epidemiology studies of CSFV (Rios et al., 2017). Thus, the 48 
phylogenetic marker based on full E2 gene was found to be the best phylogenetic marker, capable of 49 
reproducing the same phylogenetic and evolutionary information as the complete viral genome (Rios et 50 
al., 2017).  In addition, Rios et al. (2017), using the combination of Pairwise Sequence Comparison 51 
(PASC), Sequence Demarcation Tool (SDT) analyses and pairwise distance calculation, determined a 52 
reliable cut-off to accurately classify CSFV at genotype and subgenotype levels (Rios et al., 2017). Rios 53 
et al. (2017) also investigated the evolutionary forces driving the genetic diversity and evolution of 54 
CSFV, including the conception of a structural model for E2 protein and other intensive computational 55 
analyses. Thus, collecting all these relevant data required a considerable amount of time, consequently, 56 
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the dataset of CSFV sequences used in this study included only those available until April 2016. 57 
However, a growing number of CSFV both complete genome and full E2 gene sequences have been 58 
submitted to GenBank (more than 500 sequences are currently available, revised on December 1st, 2017), 59 
most of them updated after June 2016 when the study published by Rios et al. (2017) was already 60 
accomplished. In addition, at the time that the study reported by Rios et al., (2017) was under revision 61 
two new subgenotypes (1.5 and 1.6) from CSFV isolates that circulated in Brazil were reported (Silva et 62 
al., 2017). This last finding is indicative that the genetic diversity of CSFV could be broader than it was 63 
previously reported (Postel et al., 2012, Rios et al., 2017). Hence, the current study was prompted by the 64 
increasing number of sequences of CSFV available on GenBank, and follows on the previously published 65 
proposals for the classification of CSFV based on 15% of genetic distance to differ among genotypes and 66 
9% of genetic distance to consider new subgenotypes (Rios et al., 2017). Therefore, the aim of the current 67 
study was to revisit the taxonomy of CSFV at genotype and subgenotype levels, to unify nomenclature 68 
and to provide an update to the classification of CSFV. We propose here a new genotyping scheme with 69 
five well defined CSFV-genotypes (CSFV-Genotype1-5) and 14 subgenotypes (seven for each of the 70 
CSFV-Genotype1 and CSFV-Genotype2). The findings showed in the current study are relevant for 71 
molecular epidemiology approaches and will help to better understand the genetic diversity and spreading 72 
of CSFV at a global scale. 73 
Material and methods 74 
Dataset  75 
All available CSFV sequences from both the E2 full gene and the complete genome were downloaded 76 
from GenBank on December 1st, 2017 (Supplementary material TableS1). The genome region analysed in 77 
this study included the full E2 gene as previously proposed by Rios et al. (2017). After removing poor 78 
quality and redundant sequences (Supplementary material TableS1, sequence highlighted in gray), a total 79 
of 517 sequences of the E2 gene were included in the study (Supplementary material TableS1). 80 
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Multiple alignment and Model selection 81 
All sequences were aligned using the MUltiple Sequence Comparison by Log- Expectation (MUSCLE) 82 
software freely available at: https://www.ebi.ac.uk/Tools/msa/muscle. The software jModelTest 2.0 was 83 
used to estimate the best-fit model using the Akaike and Bayesian information criteria (AIC and BIC) 84 
(Darriba et al., 2012). The best-fit model selected was used for phylogenetic analysis and genetic distance 85 
calculation. 86 
Phylogenetic analysis 87 
Phylogenetic analyses were performed following the methodology suggested by Rios et al. 88 
(2017), briefly: searches for recombinant sequences and crossover regions were performed to remove the 89 
sequences with a possible recombinant event, using Geneconv, RDP, MaxChi, Chimera, BootScan, 90 
SiScan, 3Seq and LARD, all implemented in RDP3 Beta 4.1 (Martin and Rybicki, 2000). Phylogenetic 91 
relationships of the CSFV strains using the E2 complete gene marker were analyzed using a Maximum 92 
Likelihood (ML) approach. The sequences JX428945/NC_018713 belonging to the Pestivirus Aydin were 93 
used as outgroup. 94 
Calculation of pairwise nucleotide p-distances and PAirwise Sequence Comparison (PASC) analysis. 95 
Pairwise nucleotide p-distances were calculated using MEGA7 (Kumar et al., 2016). Different matrix of 96 
nucleotide divergence between groups were generated using an alpha-value=0.66 and 1000 bootstrap 97 
replicates to estimate variance. To confirm the reliability of the cut-off previously defined by Rios et al. 98 
(2017) for the different lineages of CSFV, a PASC analysis was performed. Thus, all 517 unique CSFV 99 
sequences for E2 full gene were submitted to the web tool DIVEIN (Deng et al., 2010) and a histogram 100 
based on computing the divergence/diversity among and within CSFV lineages was accomplished. 101 
Results and Discussion 102 
The PASC analyses, based on the E2 gene from the 517 E2 full gene sequences, displayed a 103 
multimodal curve (Fig. 1A), similar to the results obtained by Rios et al. (2017). Threshold values of 91% 104 
and 86% of identity allow to separate all the subgenotypes and genotypes of CSFV, respectively (Fig. 105 
1A). Thus, the cut-off values were consistent with those previously obtained by Rios et al. (2017).  It’s 106 
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important to denote that the cut-off values were not changed by the effect of the number of sequences 107 
employed. For other viral agents such as porcine circovirus type 2 (PCV2), when the taxonomy was 108 
revisited due to conflicting results obtained by different research groups (Franzo et al., 2015), it was 109 
evidenced that the increase in the number of sequences analysed yielded incompatible cut-off values 110 
(Franzo et al., 2015) compared to those previously established (Grau-Roma et al., 2008). Thus, the fact 111 
that the cut-off values to define CSFV genotypes and subgenotypes were not altered despite the 5-fold 112 
increase of the total of sequences analysed, ensures the accurate classification for this viral agent. 113 
ML tree, based on the complete E2 gene from 517 CSFV sequences, identified five main lineages 114 
(CSFV genotypes 1-5) and different sublineages (Fig. 1B). In addition, the genetic divergence among the 115 
different proposed CSFV-Genotypes ranged between 15.6%-19.1% (Fig. 1C). Thus, beside the 116 
historically recognized CSFV-Genotypes 1-3 (Postel et al., 2012), two new genotypes are proposed in this 117 
study. One of the new proposed genotypes was formed by the British CSFV strain “Congenital Tremor” 118 
isolated in 1964 (sequence ID:JQ411575) (Vilcek et al., 1996). This strain was found to be one of the 119 
most distinct strains in a phylogenetic study performed in 1996 (Vilcek et al., 1996), and it was later 120 
misplaced as outgroup, in molecular epidemiology studies of CSFV (Postel et al., 2012, Postel et al., 121 
2017). In the current study, CSFV strain “Congenital Tremor” showed a genetic divergence, compared to 122 
the remaining CSFV-genotypes, between 15.7%-17.4% (Fig. 1C). It is also important to denote that in 123 
phylogenetic analysis at species level, where rooted trees are analyzed, those sequences from species 124 
closer to the specie in study must be used as outgroup (Perez et al., 2011, Martinez et al., 2012, Barrera et 125 
al., 2017, Holland et al., 2003). Since CSFV strain “Congenital Tremor” (sequence ID: JQ411575) 126 
showed less that 20% of genetic divergence when compared to the remaining CSFV genotypes, this strain 127 
is a CSFV member and therefore, its use as outgroup is not appropriate when phylogenetic analyses are 128 
conducted at species level. However, the branch formed by this strain is divergent enough from CSFV-129 
genotype 2 to be considered a new genotype. The fact that the number of full sequences of CSFV E2 gene 130 
has increased considerably in the GenBank Database could have helped resolve this new topology 131 
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showing CSFV strain “Congenital Tremor” as a divergent lineage. Therefore, we propose this lineage to 132 
be designated as a new CSFV-genotype (CSFV-genotype 4) (Fig. 1B and C).  133 
In addition to the CSFV strain “Congenital Tremor”, the CSFV strains JJ9811 and YI9908 134 
isolated from Korea during 1998 and 1999, respectively, formed a statistically supported independent 135 
lineage (Fig.1B). This lineage showed a genetic divergence compared to the remaining CSFV-genotypes 136 
that ranged between 15.6%-19.1% (Fig. 1C). The CSFV strains JJ9811 and YI9908 have been previously 137 
classified as genotype 3, subgenotype 3.2 (Lim et al., 2016). However, this previous classification was 138 
based on the phylogenetic analysis using the segment of E2 comprising 190 nt (E2-190 marker) (Lowings 139 
et al., 1996). In a previous report, it was shown that the phylogenetic marker E2-190 (Lowings et al., 140 
1996) was associated with loss of phylogenetic information, besides, this marker was unable to reproduce 141 
the same topologies as the complete genome of CSFV or the E2-complete gene marker (Rios et al., 2017). 142 
A notable example showing the misclassification leaded by the use of the E2-190 marker is the case of the 143 
Cuban CSFV isolates, which were historically classified as subgenotype 1.2 (Diaz de Arce et al., 1999, de 144 
Arce et al., 2005, Perez et al., 2012). However, these isolates were re-classified as subgenotype 1.4 when 145 
the phylogenetic analysis was accomplished using the E2-complete gene marker showed a genetic 146 
segregation between  9.8–15.8% to sequences of subgenotype 1.2 (Postel et al., 2013). Thus, the use of 147 
the marker E2-190 (Lowings et al., 1996), could have lead to a misclassification of the CSFV strains 148 
JJ9811 and YI9908 into the subgenotype 3.2 (Lim et al., 2016). It is also relevant to consider that the 149 
lineage formed by the CSFV strains JJ9811 and YI9908 showed a genetic divergence of 16.6% with the 150 
CSFV strains belonging to the genotype 3 (Fig. 1B and C). Thus, both analyses (the topology and the 151 
genetic divergence of the lineage formed by the CSFV strains JJ9811 and YI9908) support the divergence 152 
of this new lineage and we propose to designate it as a new CSFV-genotype (CSFV-genotype 5) (Fig. 1 153 
and Supplementary Material Fig.S1).  154 
  At intra-genotype level, a new scheme of the genetic diversity was also revealed (Fig. 2, Fig. 3 155 
and Table 1). In the case of CSFV-genotype 1, seven subgenotypes were found, consisting of the four 156 
(1.1-1.4) previously recognized (Postel et al., 2013, Rios et al., 2017), the two new subgenotypes (1.5-1.6) 157 
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recently described circulating in Brazil (Silva et al., 2017), and a new subgenotype reported for the first 158 
time in the current study designated as CSFV- subgenotype 1.7 (Fig.2 and Table 1). The new subgenotype 159 
1.7 was strongly supported by bootstrap values and the genetic divergence showed in comparison with the 160 
remaining subgenotypes (Fig.2 and Table 1). Thus, the CSFV subgenotype 1.7 showed a genetic 161 
divergence ranged from 9.2% to 13.1% (Table 1).  162 
The new 1.7 subgenotype comprised 20 sequences (KX586754-KX586772, and KX586774), all 163 
from viral strains circulating in Ecuador during 2012 to 2015. Moreover, another sequence included in 164 
this study (KX586773) of a strain circulating in Ecuador in March of 2000 clustered together with the 165 
CSFV subgenotype 1.1. Hence, a switch from the subgenotype 1.1 to subgenotype 1.7 occurred in 166 
Ecuador during 2000 to 2012, caus d by an event not yet reported.  167 
Even though a phylodynamic study focused on Ecuadorian CSFV strains has been recently 168 
reported (Garrido Haro et al., 2018), no epidemiological information about this new cluster was 169 
discussed. Likewise, it’s important to highlight that the phylodynamic analysis in this study was very 170 
limited, since only the B/C domain of the E2 gene (190 nt) was considered. Although Garrido-Haro et al. 171 
(2018) sequenced the complete gene E2 from Ecuadorian strains, these authors included in their analysis 172 
Peruvian strains (Genbank Acc. No. HM070972, HM070975, HM070976, HM070977, HM070982 and 173 
HM070988 (See Figure 1 in Garrido-Haro et al. (2018)), which are partial E2 sequences, framing the B/C 174 
domain region. Therefore, all the inferences performed in the different analyses in Garrido-Haro et al. 175 
(2018) (time for the most recent common ancestor (tMRCA), Bayesian Skyline Plot (BSP) and 176 
evolutionary rates) were restricted to the B/C domain region, which has been recently described to bias 177 
the results for phylogenetic and phylodynamic approaches in CSFV (Rios et al., 2017). Therefore, further 178 
studies will be required to get a better understanding about the events supporting the switch of the 179 
subgenotype 1.1 to 1.7 in Ecuador. We also remark that the new cluster containing the CSFV-strains 180 
circulating in Ecuador was previously classified as subgenotype 1.6 together with strains that circulated in 181 
Brazil and Peru during the years 2008 and 2009 (Garrido Haro et al., 2018). However, analysing in detail 182 
the results reported by Garrido-Haro et al. (2018), it can be noted that the Ecuadorian strains formed a 183 
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segregated cluster from the Brazilian and Peruvian strains. In addition, these authors didn’t perform a 184 
genetic divergence analysis leading to a misclassification of this new group of strains circulating in 185 
Ecuador. 186 
The results obtained in the current study from the genetic divergence evaluation among all the 187 
statistically supported lineages (Fig. 2), showed that no additional subgenotypes within the CSFV-188 
genotype 1 were supported (Supplementary material TableS2).  189 
Regarding CSFV-genotype 2, besides the three previously reported subgenotypes (Postel et al., 190 
2012, Rios et al., 2017), another four subgenotypes were identified (Fig. 3, Table 1) from the 19 191 
sublineages assessed (Supplementary material TableS3). The lineage formed by sequences of CSFV 192 
strains that circulated in India during 2012-2013 formed a statistically supported cluster (Fig. 3 and 193 
Supplementary material TableS1). These sequences showed a genetic divergence of 11.9% with the 194 
subgenotype 2.1, where the strains were previously located (Ahuja et al., 2015), and a genetic divergence 195 
compared to the remaining subgenotypes into CSFV-genotype 2 that ranged between 9.1% and 13.8% 196 
(Table 1). Hence, we propose this lineage to be defined as subgenotype 2.4 (Fig. 3). Likewise, the lineage 197 
consisting of CSFV strains that circulated in China during 2008 to 2013 and in Viet Nam in 2014 (Fig. 3 198 
and Supplementary material TableS1) formed a statistically supported cluster (Fig. 3 and Supplementary 199 
material TableS1) and showed a genetic divergence of 9.1% with the subgenotype 2.1, where the strains 200 
were previously located, thus we propose to define this lineage as CSFV subgenotype 2.5 (Fig.3). It is 201 
important to highlight that both CSFV subgenotypes 2.4 and 2.5 were previously defined as subgenotypes 202 
2.1d and 2.1c, respectively (Gong et al., 2016). Gong et al. (2016) also proposed another eight 203 
subgenotypes for a total of ten new subgenotypes all diversified from the subgenotype 2.1 (Gong et al., 204 
2016).  However, a detailed analysis accomplished in Rios et al. (2017) showed that neither the genetic 205 
divergence showed by the lineages nor the statistical values in the topology resolved were enough to 206 
support the classification of these lineages as new subgenotypes (Rios et al., 2017).  207 
In the current study, a supported diversification from the branch that originated the subgenotype 208 
2.1 yielded two new lineages (subgenotype 2.4 and subgenotype 2.5) (Fig. 3). The effect of the number of 209 
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taxa on the support of the nodes in the phylogenetic tree has been previously reported as key element to 210 
be considered in the phylogenetic tree reconstruction (Simion et al., 2017, Philippe et al., 2011). In 211 
addition, it is well known that including more taxa allows a better detection of multiple substitutions, 212 
decreasing the amount of non-phylogenetic signal while preserving phylogenetic signal, which can be 213 
translated in a better resolution of the topology (Philippe et al., 2011). Therefore, the fact that the number 214 
of sequences used in the current study has been increased approximately in 3-fold in comparison with the 215 
sequences used in Gong et al. (2016) (517 sequences vs 160 sequences used in Gong et al. (2016)) clearly 216 
improved the support of the node in the topologies obtained. Likewise, it has been previously 217 
demonstrated, taking into account the postulates of the neutral theory of evolution, that genetic diversity 218 
increases with a larger effective population size (Hague and Routman, 2016). Hence, the taxa number 219 
increase could have been determinant in obtaining the genetic distance values for the subgenotypes 2.4 220 
and 2.5 (Table 1 and supplementary material TableS3). Despite these novel results, it is also relevant to 221 
denote that, non-additional subgenotypes were found from the diversification of the subgenotype 2.1 222 
(Figure 3 and supplementary material TableS3). Thus, in this regard, the present work reinforces the 223 
results previously described by Rios et al. (2017) which evidenced that subgenotypes 2.1 a,b,g,h,i and j 224 
defined by Gong et al. (2016) are not distinct enough to be regarded as new subgenotypes. 225 
In addition to the two new subgenotypes (2.4 and 2.5) which emerged from the same ancestor 226 
than subgenotype 2.1, another two subgenotypes (2.6 and 2.7) were defined into the CSFV genotype 2 227 
(Fig. 3 and Table 1). These two proposed subgenotypes, emerged from the same ancestor than 228 
subgenotype 2.2 (Fig. 3). The new proposed subgenotype 2.6 consisted of strains circulating in Viet Nam 229 
in 2014 (Supplementary information TableS1) with an ancestral CSFV strain that circulated in Italy in 230 
1998 (Supplementary information TableS1). A recent report by Hung et al. (2017) described the same 231 
topological reconstruction for these Vietnamese strains emerging from the ancestral CSFV-strain 232 
CSF0573-Parma circulating in Italy in 1998 (Hung, 2017). However, since Hung et al. (2017) only 233 
employed a total of 29 sequences of CSFV, it was not possible to obtain a genetic divergence of this 234 
cluster with an accurate resolution compared to subgenotype 2.2 (Hung, 2017). In the current study, the 235 
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independent segregation of this lineage (defined as 2.6) was statistically supported by a 100% of bootstrap 236 
value. In addition, the new proposed subgenotype 2.6 showed a genetic distance of 13.0% compared with 237 
subgenotype 2.2 (Table 1) and the genetic divergence compared with the remaining subgenotypes was 238 
ranged between 9.3% and 13.0%. Therefore, based on all the results obtained, we consider this lineage as 239 
a new subgenotype designated as 2.6 (Fig.3 and Table 1). 240 
Surprisingly, the strain Bergen isolated in Netherlands in 1977 formed an independent lineage, 241 
statistically supported with 85% of bootstrap value (Fig. 3) and showed a genetic divergence of 10.8% 242 
compared to subgenotype 2.2 (Table 1), where it was previously included (Postel et al., 2012). Relevant 243 
aspects need to be clarified regarding this result. First, the lineage proposed as the new subgenotype 2.7 244 
was composed by two non-identical sequences from the CSFV Bergen strain. This strain has four 245 
sequences on Genbank database: one sequence for the complete E2 gene (JQ411587), another sequence 246 
for the complete genome (KJ619377) and two sequences for the NS5B region (U30720 and AF182909). 247 
However, both E2 sequences for this viral strain (JQ411587 and the E2 sequence extracted from the 248 
complete genome (KJ619377)) are not identical, therefore, they were analyzed independently. Second, in 249 
a previous report, it was highlighted that CSFV-strain Netherlands/JQ411587 “Bergen” (CSF0906) 250 
partially displayed a higher genetic similarity to some genotype 2.1 isolates than to different 2.2 isolates, 251 
disturbing the segregation of 2.1 and 2.2 isolates (Postel et al., 2012). However, since Postel et al. (2012) 252 
only used 33 CSFV sequences, they also faced the trouble of acquiring both an accurate resolution and a 253 
proper genetic divergence of this new cluster compared the subgenotype 2.2.  254 
On the other hand, for the remining genotypes (CSFV-genotype 3, CSFV-genotype 4 and CSFV-255 
genotype 5) a diversification in additional subgenotypes was not detected (Supplementary material Fig. 256 
S2, Table S4 and S5).  257 
In the current study, a new classification scheme for CSFV is proposed. The increased number of 258 
CSFV sequences available on GenBank database, especially of the full E2 gene, facilitated obtaining a 259 
better resolution for the topology of CSFV-tree. In addition, the establishment of a reliable cut-off value 260 
by Rios et al. (2017) made possible to accurately define genotypes and subgenotypes for CSFV. Similar 261 
Page 11 of 37
Transboundary and Emerging Diseases - submitted manuscript
Transboundary and Emerging Diseases - submission proof
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
12 
 
approaches have been accomplished for other viral agents. Thus, the growing number of sequences for 262 
infectious bursal disease virus (IBDV) and the use of phylogenetic methodologies have enabled a new 263 
classification of this viral agent into seven genogroups, updating the previous classification which only 264 
recognized three groups (Michel and Jackwood, 2017). Likewise, for porcine circovirus type 2 (PCV2), a 265 
new genotype has been added to the previous taxonomic classification, after the analysis of approximately 266 
3300 new sequences of the complete genome of this virus (Franzo et al., 2016), which were submitted to 267 
GenBank database after the first taxonomical classification for PCV2 had been accomplished (Grau-268 
Roma et al., 2008). The current study also highlights the importance of submitting non-redundant 269 
sequences for CSFV. Although a new classification scheme is provided here, it is relevant to denote that 270 
some phylogenetic clades have better representation of viral isolates than others. Thus, we encourage the 271 
different research groups to increase their molecular epidemiology studies regarding CSFV, which can 272 
stimulate the acquisition of new representative CSFV sequences. Finally, the results presented here will 273 
facilitate future analyses focused on elucidating evolutionary relationships among different CSFV 274 
isolates. The update in the classification of CSFV will allow the scientific community to establish more 275 
accurately the links among different outbreaks of the disease.  276 
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 Table 1. Genetic distances based on full-length E2 gene sequences of CSFV for different subgenotypes. Values above the diagonal 
represent the standard error, values below the diagonal represent the p-distance values obtained using MEGA7 and 1000 bootstrap 
replicates 
Subgenotype 1.1 1.2 1.3 1.4 1.5 1.6 1.7 2.1 2.2 2.3 2.4 2.5 2.6 2.7 
1.1   0.007 0.008 0.009 0.002 0.001 0.002   
1.2 0.096   0.006 0.004 0.008 0.009 0.005   
1.3 0.104 0.102   0.009 0.001 0.001 0.009   
1.4 0.116 0.107 0.120   0.011 0.001 0.001   
1.5 0.096 0.131 0.138 0.134   0.007 0.009   
1.6 0.095 0.118 0.137 0.134 0.098   0.009   
1.7 0.096 0.104 0.128 0.131 0.108 0.106     
2.1   0.008 0.012 0.011 0.002 0.001 0.008 
2.2 0.134   0.008 0.012 0.012 0.012 0.012 
2.3 0.138 0.130   0.012 0.013 0.012 0.012 
2.4 0.119 0.135 0.136   0.012 0.012 0.001 
2.5 0.097 0.130 0.138 0.113   0.004 0.001 
2.6 0.099 0.130 0.130 0.107 0.097   0.001 
2.7               0.147 0.108 0.131 0.139 0.133 0.146   
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Fig. 1. Representation of frequency distribution of pairwise distance, the phylogenetic tree and genetic 
distance for all the five-main lineage of CSFV.  A) PASC results: the cut-off values genotype (14.3%) and 
subgenotype (9.3%) of genetic divergence were denoted. B) All no-redundant genomes were analysed using 
ML-method, the GenBank IDs for all the sequence is shown, the main lineages proposed as CSFV-genotypes 
are denoted (CSFV-genotype 1: green, CSFV-genotype 2: blue, CSFV-genotype 3: red, CSFV-genotype 4: 
purple, and CSFV-genotype 5: orange (this tree has been used with representation purposes only, an 
additional tree showing the significance value for the nodes is shown in Supplementary material Fig.S1.C) P-
distance between CSFV-genotypes, 1, 2, 3, 4 and 5: Indicates the CSFV genotypes 1, 2, 3, 4 and 5, 
respectively. Values above the diagonal represent the standard error, values below the diagonal represent 
the p-distance values obtained using MEGA7 and 1000 bootstrap replicates.  
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Fig. 2. Phylogenetic tree for CSFV genotype 1. All non-redundant genomes were analysed using ML-method, 
the GenBank IDs for all the sequences are shown. All the lineages assessed within the CSFV genotype 1 
(green) are denoted with black circles, the main sublineages proposed as CSFV subgenotypes within CSFV 
genotype 1 are denoted. All the remaining CSFV genotypes were collapsed: CSFV-genotype 2: blue, CSFV-
genotype 3: red, CSFV-genotype 4: purple, and CSFV-genotype 5: orange. Numbers along the branches 
refer to the percentages of confidence and minor branch values were hidden.  
 
139x153mm (300 x 300 DPI)  
 
 
Page 17 of 37
Transboundary and Emerging Diseases - submitted manuscript
Transboundary and Emerging Diseases - submission proof
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
  
 
 
Fig. 3. Phylogenetic tree for CSFV genotype 2. All non-redundant genomes were analysed using ML-method, 
the GenBank IDs for all the sequences are shown. All the lineages assessed within the CSFV genotype 2 
(blue) are denoted with black circles, the main sublineages proposed as CSFV subgenotypes within CSFV 
genotype 2 are denoted. All the remaining CSFV genotypes were collapsed: CSFV-genotype 1: green, CSFV-
genotype 3: red, CSFV-genotype 4: purple, and CSFV-genotype 5: orange. Numbers along the branches 
refer to the percentages of confidence and minor branch values were hidden  
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GenBank ID Country Collection Date
AF352565 Taiwan Not available
AB897785 Japan 2012
D49533 Japan Not available
D49532 Japan Not available
AF407339 China Not available
LT593749 Not available Not available
LT593750 Not available Not available
LT593751 Not available Not available
LT593757 Not available Not available
LT593758 Not available Not available
LT593748 Not available Not available
LT593754 Not available Not available
LT593760 Not available Not available
KY849593 Serbia 2005
KY849594 Serbia 2006
LT593752 Not available Not available
LT593753 Not available Not available
LT593755 Not available Not available
LT593756 Not available Not available
LT593759 Not available Not available
LT593761 Not available Not available
LT593762 Not available Not available
JQ595295 Belgium 1993-1994
AY072924 Denmark Not available
LC016722 Thailand 1993
JQ411563 Germany 1992
JQ411564 Germany 1994
JQ411565 Austria 1994
JQ411568 Poland 1995
JQ411572 Czech Republic 1996
JQ411574 Germany 1997
JQ411576 Germany 1995
JQ411577 Germany 1997
JQ411580 Germany 1998
JQ411581 Germany 1998
JQ411583 Slovakia 2000
JQ411584 Germany 2000
JQ411585 Spain 2001
JQ411586 Croatia 2006
JQ411559 Germany 1984
JQ411560 Germany 1989
JQ411561 Germany 1989
JQ411562 Austria 1990
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JQ411566 Germany 1997
JQ411567 Netherlands 1997
JQ411569 Poland 1995
JQ411570 Malaysia 1986
JQ411571 Japan 1974
JQ411573 Czech Republic 1994
JQ411575 United Kingdom 1964
JQ411578 Germany 1982
JQ411579 Italy 1998
JQ411582 United Kingdom 2000
JQ411587 Netherlands Not available
JQ411588 Italy 1951
JQ411589 Hungary 2007
JQ411590 Slovakia 2007
JQ411591 Lithuania 2009
JX028200 Guatemala Not available
JX028202 Cuba 2009
JX028204 Cuba 2010
JX028201 Cuba 1958
JX028203 Cuba 2011
AY526726 Taiwan 2003
AY526727 Taiwan 1994
AY526728 Taiwan 2001
AY526729 Taiwan 1995
AY526730 Taiwan 1996
AY526731 Taiwan 1990
AY526732 Taiwan
U35069 Taiwan Not available
U35740 Taiwan Not available
X71780 United Kingdom Not available
AJ704817 Cuba
EU567076 India
EU567077 India
EU567078 India
 FJ160901 India
KF007902 India 2012
KF007919 India 2011
HQ697222 China 2008
HQ697223 China 2008
HQ697224 China 2009
HQ697225 China 2009
HQ697226 China 2010
HQ697227 China 2009
HQ697228 China 2009
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 HCU03290 Not available Not available
AH007708 Not available Not available
DQ907712 Not available Not available
DQ907713 Not available Not available
DQ907714 Not available Not available
DQ907715 Not available Not available
DQ907716 Not available Not available
DQ907719 Not available Not available
NM_001204369 Not available Not available
KX130940 Indonesia 2013
AF143082 China Not available
AF143092 China Not available
AF143083 China Not available
AF143084 China Not available
AF143085 China Not available
AF143086 China Not available
AF143087 China Not available
AF143088 China Not available
AF143089 China Not available
AF143090 China Not available
AF143091 China Not available
KY990413 Not available Not available
KY990414 Bangladesh 2015
KY990415 Bangladesh 2015
HCU72047 Not available Not available
HCU72048 Not available Not available
KC533781 India 2009
KC533787 India 2010
AY430287 Not available Not available
DQ907717 Not available Not available
DQ907718 Not available Not available
DQ907720 Not available Not available
KC533782 India Not available
AY027672 Not available Not available
AY027673 Not available Not available
EF683605 China Not available
EF683606 China Not available
EF683607 China Not available
EF683608 China Not available
EF683609 China Not available
EF683610 China Not available
EF683611 China Not available
EF683612 China Not available
EF683613 China Not available
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EF683614 China Not available
EF683615 China Not available
EF683616 China Not available
EF683617 China Not available
EF683618 China Not available
EF683619 China Not available
EF683620 China Not available
EF683621 China Not available
EF683622 China Not available
EF683623 China Not available
FJ456865 China 2007
FJ456866 China 2007
FJ456867 China 2006
FJ456868 China 2007
FJ456869 China 2005
FJ456870 China 2004
FJ456871 China 2005
FJ456872 China 2006
FJ456873 China 2006
FJ456874 China 2006
FJ456875 China 2004
FJ456876 China 2007
FJ582642 China 2008
FJ582643 China 2008
FJ582644 China 2008
FJ598609 China 2008
FJ598610 China 2008
FJ598611 China 2008
FJ598612 China 2008
FJ607779 China 2008
FJ607780 China 2008
FJ977628 China 2009
HM190299 South Africa 2005
HQ317681 China 2010
HQ380232 China 2009
HQ380233 China 2010
HQ380234 China 2009
HQ380235 China 2008
HQ380236 China 2008
HQ380237 China 2008
HQ380238 China 2009
HQ380239 China 2009
HQ380240 China 2009
HQ380241 China 2009
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HQ380242 China 2010
HQ380243 China 2010
HQ380244 China 2009
HQ380245 China 2009
JN882005 China 2011
JQ001833 China 2011
JQ001834 China 2011
JN886990 China 2011
JQ411592 Lithuania 2011
JQ411593 Lithuania 2011
JQ411594 Lithuania 2011
JQ411595 Lithuania 2011
JQ411596 Lithuania 2011
JQ411597 Lithuania 2011
JQ411598 Lithuania 2011
JQ411599 Lithuania 2011
JQ411600 Lithuania 2011
JQ411601 Lithuania 2011
JX162240 Nepal 2011
JX162241 Nepal 2011
JX898523 China 2011
JX898524 China 2012
JX898525 China 2012
KC597187 China 2012
KC809979 China 2011
KC809980 China 2012
KC809981 China 2011
KC809982 China 2011
KC809983 China 2011
KC809984 China 2011
KC809985 China 2011
KC809986 China 2012
KC867687 China 2011
KC867688 China 2012
KC867689 China 2012
KF297337 Romania 2007
KF233944 Bulgaria 1997
KF233945 Croatia 1997
KF233946 Not available 2000
KF233947 Bulgaria 2002
KF233948 Romania 2004
KF233949 Bulgaria 2006
KF233950 Serbia 2006
KF233951 Bulgaria 2007
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KF233952 Bulgaria 2007
KF233953 Croatia 2007
KF233954 Romania 2006
KF233955 Romania 2006
KF233956 Romania 2007
KF233957 Bulgaria 2008
KF233958 Israel 2009
KF233959 Bulgaria 2009
KF233960 Serbia 2010
KF233961 Latvia 2013
KJ661548 China 2008
LC000001 India 2013
LC000002 India 2012
LC029886 India 2012
KP702206 Viet Nam 2014
KP702207 Viet Nam 2014
KP702208 Viet Nam 2014
KP702209 Viet Nam 2014
KP702210 Viet Nam 2014
KR054034 India Not available
KR054035 India Not available
KR054036 India Not available
KR054037 India Not available
KR054038 India Not available
KR054039 India Not available
KR054040 India Not available
KR054041 India Not available
KR054042 India Not available
KR054043 India Not available
KR054044 India Not available
KR054045 India Not available
KR054046 India Not available
KR054047 India Not available
KR054048 India Not available
KR054049 India Not available
KR054050 India Not available
KR054051 India Not available
KR054052 India Not available
KT953587 China 2015
KT953588 China 2015
KT953589 China 2014
KT953590 China 2015
KT953591 China 2015
KT953592 China 2013
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KT953593 China 2015
KT953594 China 2015
KT953595 China 2015
 KT953596 China 2015
KT953597 China 2015
KT953598 China 2015
KT953599 China 2015
KT953600 China 2015
KT953601 China 2015
KT953602 China 2015
KT953603 China 2015
KT953604 China 2014
KT953605 China 2015
KT953606 China 2015
KT953607 China 2015
KT953608 China 2015
KT953609 China 2015
KT953610 China 2015
KT953611 China 2015
KT853102 China 2011
KT853103 China 2011
KT853104 China 2011
KT853105 China 2011
KT853106 China 2011
KT853107 China 2011
KT853108 China 2011
KT853109 China 2011
KT853110 China 2011
KT853111 China 2011
KT853112 China 2011
KT853113 China 2011
KT853114 China 2011
KT853115 China 2011
KT853116 China 2011
KU375249 China 2014
KU375250 China 2014
KU375251 China 2014
KU375252 China 2012
KU375253 China 2013
KU375254 China 2015
KU375255 China 2015
KU375256 China 2014
KU375257 China 2014
KU375258 China 2014
Page 25 of 37
Transboundary and Emerging Diseases - submitted manuscript
Transboundary and Emerging Diseases - submission proof
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
KU375259 China 2014
KU375260 China 2014
KU375261 China 2014
KU375262 China 2014
KU375263 China 2015
KX431227 Brazil 2008
KX431228 Brazil 2001
KX431229 Brazil 2003
KX431230 Brazil 2003
KX431231 Brazil 2004
KX431232 Brazil 2009
KX431233 Brazil 2009
KX687712 Germany 1989
KX687713 Croatia 2002
KX687714 Croatia 2002
KX687715 Romania 1994
KX687716 Croatia 2007
KX687717 Bulgaria 1998
 KX687718 Bulgaria 2002
KX687719 Slovakia 2007
KX687720 Germany 1993
KX687721 Hungary 1992
KX759642 China 2009
KX759643 China 2006
KX257416 China Not available
KX586754 Ecuador 2015
KX586755 Ecuador 2014
KX586756 Ecuador 2013
KX586757 Ecuador 2014
KX586758 Ecuador 2014
KX586759 Ecuador 2014
KX586760 Ecuador 2015
KX586761 Ecuador 2015
KX586762 Ecuador 2012
KX586763 Ecuador 2015
KX586764 Ecuador 2015
KX586765 Ecuador 2015
KX586766 Ecuador 2015
KX586767 Ecuador 2015
KX586768 Ecuador 2015
 KX586769 Ecuador 2015
KX586770 Ecuador 2015
KX586771 Ecuador 2013
KX586772 Ecuador 2012
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KX586773 Ecuador 2000
KX586774 Ecuador 2015
KY816735 Not available 2014
KY816736 Not available 2014
KY816737 Not available 2014
KY816738 Not available 2014
KY816739 Not available 2014
KX844724 Not available 2014
KX880080 China 2015
KX880081 China 2014
KX880082 China 2016
KX880083 China 2015
KX880084 China 2014
KX880085 China 2016
KX880086 China 2016
KX880087 China 2016
KX880088 China 2015
KX880089 China 2016
KX898427 China 2014
KX898428 China 2014
KX898429 China 2014
KX898430 China 2014
KX898431 China 2014
KX898432 China 2014
KX898433 China 2014
KX886270 China 2015
KX886271 China 2016
KX886272 China 2016
KX886273 China 2015
KX886274 China 2015
KX886275 China 2015
KX886276 China 2015
KX886277 China 2016
KX886278 China 2015
KX886279 China 2014
HCU43924 Not available Not available
AF134207 Thailand Not available
AF134208 Thailand Not available
AF134209 Thailand Not available
AF134210 Thailand Not available
KC533777 India 2011
KC533779 India 2011
AY450271 Not available Not available
AY450272 Not available Not available
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AY450273 Not available Not available
AY450274 Not available Not available
AY450275 Not available Not available
AY450276 Not available Not available
AY450277 Not available Not available
AY450278 Not available Not available
AY450279 Not available Not available
AY450280 Not available Not available
AY450281 Not available Not available
AY450282 Not available Not available
AY450283 Not available Not available
AY450284 Not available Not available
EF014327 Not available Not available
EF014328 Not available Not available
EF014329 Not available Not available
EF014330 Not available Not available
EF014331 Not available Not available
EF014332 Not available Not available
EF014333 Not available Not available
EF014334 Not available Not available
EF014335 Not available Not available
EF014336 Not available Not available
EF014337 Not available Not available
EF014338 Not available Not available
KC533783 India 2006
AY430095 Not available Not available
AY430096 Not available Not available
KX345847 Bangladesh 2015
KP195022 India 2014
AF091507 Not available Not available
AF091661 Italy 1951
AF092448 China Not available
AF099102 Russia Not available
AF326963 Germany 1965
AF333000 China Not available
AF531433 China Not available
AY259122 Switzerland Not available
AY367767 China Not available
AY382481 China Not available
AY554397 Taiwan Not available
AY578687 Italy 2001
AY578688 Not available 2001
AY646427 Taiwan 1994
AY663656 China 2003
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AY775178 China 1945
AY805221 China Not available
DQ127910 China 2004
EU490425 France Not available
EU497410 China 2006
EU789580 Japan 1980
EU857642 India Not available
FJ265020 Spain 2001
FJ529205 China 2010
GQ122383 China 2006
GQ902941 Denmark Not available
GQ923951 China 2009
GU233731 Germany 2006
GU233732 Germany 2005
GU233733 Germany 2009
GU233734 Germany 2009
GU324242 Germany 2004
GU592790 China 2009
HM175885 China 2008
HM237795 Czech Republic Not available
HQ148061 Croatia 2002
HQ148062 Bulgaria 2007
HQ148063 Lithuania 2009
HQ380231 China 2009
J04358 Germany 1999
JQ268754 China 2010
JQ861548 India 2011
JX218094 China 2012
JX262391 China 2011
KC149990 South Korea 2011
KC149991 South Korea 2011
KC503764 India 2011
KC533775 India 2006
KC533776 India Not available
KC533793 India 2011
KC851953 India 2012
KF669877 South Korea 1998
KJ619377 Netherlands 1977
KJ873238 USA 1994
KM262189 India 2009
KM362426 India Not available
KM522833 USSR Not available
KP233070 China 2013
KP233071 China 2013
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KP343640 China 2011
KT119352 China 2014
KT716271 South Korea 1999
KU504339 China 2011
KU556758 China 2015
KX064281 China 2015
KX576461 Cuba 2010
KX870109 South Korea 2016
KY132096 China 2011
KY290453 South Korea 2016
KY860615 India 2013
LC086647 Mongolia 2014
LT158401 Not available Not available
LT158402 Not available Not available
LT158403 Not available Not available
LT158404 Not available Not available
LT158405 Not available Not available
LT158406 Not available Not available
LT158407 Not available Not available
LT158408 Not available Not available
LT158409 Not available Not available
LT158410 Not available Not available
LT158502 Not available Not available
M31768 Netherlands Not available
NC_00265 Switzerland 2000
U35069 Taiwan Not available
U35740 Taiwan Not available
U43924 Taiwan Not available
U45477 Germany Not available
U72047 China Not available
U72048 Not available Not available
U90951 France Not available
X87939 Switzerland Not available
X96550 Switzerland Not available
LT593749 Duplicated
LT593750 Duplicated
LT593751 Duplicated
LT593757 Duplicated
LT593758 Duplicated
LT593748 Duplicated
LT593754 Duplicated
LT593760  Duplicated
LT593753 Duplicated
LT593755 Duplicated
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LT593756 Duplicated
LT593761 Duplicated
LT593762 Duplicated
KF007902 Duplicated
KF007919 Duplicated
HQ697227 Duplicated
HQ697228 Duplicated
KY990413 Duplicated
KY990414 Duplicated
KY990415 Duplicated
KC533781 Duplicated
KC533787 Duplicated
HQ380235 Duplicated
HQ380244 Duplicated
HQ380245 Duplicated
JQ411593 Duplicated
JQ411594 Duplicated
JQ411595 Duplicated
JQ411596 Duplicated
JQ411597 Duplicated
JQ411598 Duplicated
JQ411599 Duplicated
JQ411600 Duplicated
JQ411601 Duplicated
KT853104 Duplicated
KT853108 Duplicated
KT853109 Duplicated
KT853110 Duplicated
KT853112 Duplicated
KT853114 Duplicated
KT853113 Duplicated
KT853115 Duplicated
KU375249 Duplicated
KU375250 Duplicated
KX586760 Duplicated
KX586765 Duplicated
KX586768 Duplicated
KX586769 Duplicated
Page 31 of 37
Transboundary and Emerging Diseases - submitted manuscript
Transboundary and Emerging Diseases - submission proof
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
Table S2. Genetic distances based on full-length E2 gene sequences of all the lineages assessed 
within the CSFV genotype 1. Values above the diagonal represent the standard error, values 
below the diagonal represent the p-distance values obtained using MEGA7 and 1000 bootstrap 
replicates. 
Subgenotype 1.1 1.2 1.3 1.4 1.5 1.6 1.7 1.8 1.9 1.10 1.11 
1.1   0.007 0.008 0.009 0.002 0.001 0.002 0.005 0.005 0.006 0.004 
1.2 0.096   0.006 0.004 0.008 0.009 0.005 0.007 0.007 0.008 0.007 
1.3 0.104 0.102   0.009 0.001 0.010 0.009 0.008 0.008 0.009 0.008 
1.4 0.116 0.107 0.120   0.011 0.010 0.010 0.010 0.009 0.010 0.010 
1.5 0.096 0.131 0.138 0.134   0.007 0.009 0.008 0.008 0.008 0.008 
1.6 0.095 0.118 0.137 0.134 0.098   0.009 0.008 0.008 0.009 0.008 
1.7 0.096 0.104 0.128 0.131 0.108 0.106   0.008 0.008 0.009 0.009 
1.8 0.041 0.083 0.099 0.113 0.089 0.081 0.085   0.005 0.006 0.005 
1.9 0.049 0.083 0.102 0.111 0.100 0.090 0.091 0.044   0.006 0.005 
1.10 0.055 0.100 0.113 0.123 0.106 0.101 0.100 0.061 0.069   0.006 
1.11 0.032 0.078 0.098 0.104 0.087 0.081 0.088 0.039 0.046 0.054   
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Table S3. Genetic distances based on full-length E2 gene sequences of all the lineages assessed within the CSFV genotype 2. Values 
above the diagonal represent the standard error, values below the diagonal represent the p-distance values obtained using MEGA7 and 
1000 bootstrap replicates. 
 
Subgenotype 2.1 2.2 2.3 2.4 2.5 2.6 2.7 2.8 2.9 2.10 2.11 2.12 2.13 2.14 2.15 2.16 2.17 2.18 2.19 
2.1   0.008 0.012 0.011 0.002 0.001 0.008 0.006 0.005 0.008 0.009 0.008 0.011 0.013 0.011 0.013 0.012 0.013 0.013 
2.2 0.134   0.008 0.012 0.012 0.012 0.012 0.012 0.012 0.012 0.012 0.012 0.010 0.010 0.008 0.006 0.009 0.012 0.012 
2.3 0.138 0.130   0.012 0.013 0.012 0.012 0.012 0.012 0.013 0.012 0.012 0.011 0.011 0.012 0.012 0.011 0.008 0.005 
2.4 0.119 0.135 0.136   0.012 0.012 0.001 0.012 0.011 0.012 0.011 0.011 0.012 0.012 0.013 0.013 0.013 0.013 0.013 
2.5 0.097 0.130 0.138 0.113   0.004 0.001 0.009 0.009 0.010 0.010 0.008 0.011 0.012 0.011 0.012 0.012 0.013 0.013 
2.6 0.099 0.130 0.130 0.107 0.097   0.001 0.008 0.009 0.010 0.010 0.008 0.011 0.013 0.012 0.012 0.012 0.014 0.013 
2.7 0.147 0.108 0.131 0.139 0.133 0.146   0.007 0.007 0.009 0.008 0.007 0.010 0.012 0.011 0.012 0.012 0.013 0.012 
2.8 0.051 0.139 0.138 0.114 0.081 0.064 0.059   0.007 0.006 0.009 0.007 0.010 0.012 0.011 0.012 0.012 0.013 0.012 
2.9 0.051 0.138 0.140 0.111 0.086 0.069 0.064 0.053   0.010 0.008 0.009 0.011 0.012 0.012 0.013 0.012 0.014 0.013 
2.10 0.063 0.142 0.152 0.122 0.083 0.077 0.074 0.057 0.064   0.010 0.009 0.011 0.013 0.012 0.013 0.013 0.014 0.013 
2.11 0.077 0.138 0.137 0.105 0.083 0.074 0.061 0.070 0.074 0.074   0.007 0.010 0.012 0.011 0.012 0.012 0.013 0.012 
2.12 0.064 0.127 0.122 0.083 0.062 0.054 0.040 0.054 0.060 0.063 0.057   0.010 0.012 0.011 0.012 0.012 0.013 0.012 
2.13 0.081 0.096 0.093 0.107 0.098 0.098 0.081 0.090 0.089 0.112 0.101 0.073   0.010 0.010 0.011 0.009 0.012 0.011 
2.14 0.099 0.540 0.129 0.093 0.094 0.091 0.132 0.142 0.135 0.150 0.135 0.122 0.081   0.010 0.011 0.009 0.012 0.012 
2.15 0.136 0.078 0.122 0.142 0.119 0.125 0.119 0.128 0.127 0.136 0.128 0.110 0.081 0.096   0.008 0.008 0.013 0.012 
2.16 0.134 0.046 0.130 0.143 0.126 0.115 0.122 0.128 0.127 0.136 0.131 0.115 0.080 0.092 0.056   0.009 0.013 0.012 
2.17 0.130 0.079 0.106 0.123 0.121 0.112 0.110 0.120 0.117 0.141 0.119 0.107 0.060 0.077 0.069 0.055   0.012 0.011 
2.18 0.147 0.137 0.054 0.140 0.137 0.139 0.125 0.135 0.138 0.154 0.138 0.118 0.087 0.121 0.119 0.127 0.101   0.007 
2.19 0.136 0.123 0.033 0.127 0.131 0.123 0.117 0.124 0.127 0.141 0.124 0.106 0.073 0.114 0.105 0.110 0.087 0.028   
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Table S4. Genetic distances based on full-length E2 gene sequences of all the lineages assessed 
within the CSFV genotype 3. Values above the diagonal represent the standard error, values 
below the diagonal represent the p-distance values obtained using MEGA7 and 1000 bootstrap 
replicates. 
Subgenotype 3.1 3.2 3.3 
3.1   0.007 0.006 
3.2 0.047   0.004 
3.3 0.044 0.022   
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Table S5. Genetic distances based on full-length E2 gene sequences of all the lineages assessed 
within the CSFV genotype 5. Values above the diagonal represent the standard error, values 
below the diagonal represent the p-distance values obtained using MEGA7 and 1000 bootstrap 
replicates. 
Subgenotype 5.1 5.2 
5.1   0.006 
5.2 0.045   
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Figure S2  
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